Skip to main content
. 2023 Dec 27;14(6):2549–2558. doi: 10.21037/jgo-23-590

Figure 1.

Figure 1

Treatment was evaluated based on RECIST V.1.1 criteria. CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.